All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
The recent investment by a global private equity firm in a Chinese device maker reflects the continuous and rising flow of capital into China's life science sector, a trend that is expected to continue as the interaction between primary and secondary markets expands.